TargAnox
Drugs that help treat oncology and metabolic related inllnesses.
Launch date
Market cap
-
Enterprise valuation
€19—28m (Dealroom.co estimates Mar 2009.)
Boston Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$5.1m | Series A | ||
| Total Funding | €4.6m | ||
Related Content
Recent News about TargAnox
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.